Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia

European Journal of Haematology

Volumn 78, Issue 5, 2007, Pages 365-373

  Rigolin, Gian Matteo ^a   Mauro, Endri ^a   Ciccone, Maria ^a   Fraulini, Chiara ^a   Sofritti, Olga ^a   Castoldi, Gianluigi ^a   Cuneo, Antonio ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Acute myeloid leukaemia; Circulating endothelial cells; Endothelial progenitor cells; Vasculogenesis

Indexed keywords

CD133 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL; STEM CELL;

ACUTE DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; NEOPLASM CIRCULATING CELLS;

EID: 34147145498     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00839.x     Document Type: Article

References (34)

1. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000;96:2240-5.
2. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000;95:309-13.
3. Aguayo A, Estey E, Kantarjian H, Mansouri T, Gidel C, Keating M, Giles F, Estrov Z, Barlogie B, Albitar M. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 1999;94:3717-21.
4. Fiedler W, Graeven U, Ergun S, Verago S, Kilic N, Stockschlader M, Hossfeld DK. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997;89:1870-5.
5. Dias S, Hattori K, Zhu Z, et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Inv 2000;106:511-21.
6. Schliemann C, Bieker R, Padro T, Kessler T, Hintelmann H, Buchner T, Berdel WE, Mesters RM. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia. Haematologica 2006;91:1203-11.
7. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-201.
8. Hilbe W, Dirnhofer S, Oberwasserlechner F, Schmid T, Gunsilius E, Hilbe G, Woll E, Kahler CM. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Path 2004;57:965-9.
9. Peters BA, Diaz LA, Polyak K, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005;11:261-2.
10. Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001;97:3658-61.
11. Beerepoot LV, Mehra N, Vermaat JS, Zonnenberg BA, Gebbink MF, Voest EE. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004;15:139-45.
12. Streubel B, Chott A, Huber D, Exner M, Jager U, Wagner O, Schwarzinger I. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 2004;351:250-9.
13. Rigolin GM, Fraulini C, Ciccone M, Mauro E, Bugli AM, De Angeli C, Negrini M, Cuneo A, Castoldi G. Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood 2006;107:2531-5.
14. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95.
15. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 2003;3:411-21.
16. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-5.
17. ISCN. ISCN Guidelines for cancer cytogenetics. In: Mitelman F, ed. Supplement to an International System for Human Cytogenetic Nomenclature. Basel: Karger, 1985, 10-215.
18. Rigolin GM, Della Porta M, Bugli AM, Castagnari B, Mauro E, Zenone Bragotti L, Ciccone M, Cuneo A, Castoldi G. Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings. Eur J Haematol 2004;73:351-8.
19. Bardin N, George F, Mutin M, Brisson C, Horschowski N, Frances V, Lesaule G, Sampol J. S-Endo 1, a panendothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 1996;48:531-9.
20. Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP Jr. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 2005;106:2923-4.
21. Rigolin GM, Della Porta M, Ciccone M, et al. In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34 cells. Br J Haematol 2004;126:501-7.
22. Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kienast J, Buchner T, Berdel WE, Mesters RM. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000;95:2637-44.
23. Wierzbowska A, Robak T, Krawczynska A, Wrzesien-Kus A, Pluta A, Cebula B, Smolewski P. Circulating endothelial cells in patients with acute myeloid leukemia. Eur J Haematol 2005;75:492-7.
24. Fang B, Zheng C, Liao L, Han Q, Sun Z, Jiang X, Zhao RC. Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood 2005;105:2733-40.
25. Gunsilius E, Duba HC, Petzer AL, Kahler CM, Grunewald K, Stockhammer G, Gabl C, Dirnhofer S, Clausen J, Gastl G. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 2000;355:1688-91.
26. Fidel IJ, Ellis LM. Neoplastic angiogenesis. Not all blood vessels are created equal. N Engl J Med 2004;351:215-6.
27. Korbling M, Estrov Z. Adult stem cells for tissue repair. A new therapeutic concept? N Engl J Med 2003;349:570-82.
28. Rigolin GM, Della Porta M, Bigoni R, Tieghi A, Cuneo A, Castoldi G. Dendritic cells in acute promyelocytic leukaemia. Br J Haematol 2001;114:830-3.
29. Friedl P. Cell fusion: new mechanisms of plasticity in cancer? Lancet Oncol 2005;6:916-8.
30. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 2005;5:899-904.
31. Pawelek JM. Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 2005;6:988-93.
32. Hida K, Klagsbrun M. A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities. Cancer Res 2005;65:2507-10.
33. Pasqualucci L, Liso A, Martelli MP, et al. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: impact on WHO classification. Blood, prepublished online August 22, 2006; DOI 10.1182/blood-2006-06-026716.
34. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenic therapy? Nat Rev Cancer 2002;2:826-35.